An innovative method for extracting isotopic information from low-resolution gamma spectra

A method is described for the extraction of isotopic information from attenuated gamma ray spectra using the gross-count material basis set (GC-MBS) model. This method solves for the isotopic composition of an unknown mixture of isotopes attenuated through an absorber of unknown material. For binary isotopic combinations the problem is nonlinear in only one variable and is easily solved using standard line optimization techniques. Results are presented for NaI spectrum analyses of various binary combinations of enriched uranium, depleted uranium, low burnup Pu, {sup 137}Cs, and {sup 133}Ba attenuated through a suite of absorbers ranging in Z from polyethylene through lead. The GC-MBS method results are compared to those computed using ordinary response function fitting and with a simple net peak area method. The GC-MBS method was found to be significantly more accurate than the other methods over the range of absorbers and isotopic blends studied

A demonstration of the gross count tomographic gamma scanner (GC-TGS) method for the nondestructive assay of transuranic waste

The authors examined the accuracy and sensitivity levels for three variations on the TGS method: the original TGS method using a high-purity germanium (HPGe) detector to measure net areas of full-energy gamma-ray peaks; a modified HPGe-detector method that uses net areas for the transmission analysis and the gross count TGS (GC-TGS) method for the emission analysis; and a NaI-detector method that uses the GC-TGS method exclusively. They found that while the accuracies of the methods were comparable, the GC-TGS method boosted the sensitivity per detector by a factor of approximately two for the HPGe GC variation and four for the NaI method. The implications for improved TGS scanner design are discussed

Pion-nucleus elastic scattering on 12C, 40Ca, 90Zr, and 208Pb at 400 and 500 MeV

Pion-nucleus elastic scattering at energies above the Delta(1232) resonance is studied using both pi+ and pi- beams on 12C, 40Ca, 90Zr, and 208Pb. The present data provide an opportunity to study the interaction of pions with nuclei at energies where second-order corrections to impulse approximation calculations should be small. The results are compared with other data sets at similar energies, and with four different first-order impulse approximation calculations. Significant disagreement exists between the calculations and the data from this experiment

B Cells Regulate Neutrophilia during Mycobacterium tuberculosis Infection and BCG Vaccination by Modulating the Interleukin-17 Response

We have previously demonstrated that B cells can shape the immune response to Mycobacterium tuberculosis, including the level of neutrophil infiltration and granulomatous inflammation at the site of infection. The present study examined the mechanisms by which B cells regulate the host neutrophilic response upon exposure to mycobacteria and how neutrophilia may influence vaccine efficacy. To address these questions, a murine aerosol infection tuberculosis (TB) model and an intradermal (ID) ear BCG immunization mouse model, involving both the μMT strain and B cell-depleted C57BL/6 mice, were used. IL (interleukin)-17 neutralization and neutrophil depletion experiments using these systems provide evidence that B cells can regulate neutrophilia by modulating the IL-17 response during M. tuberculosis infection and BCG immunization. Exuberant neutrophilia at the site of immunization in B cell-deficient mice adversely affects dendritic cell (DC) migration to the draining lymph nodes and attenuates the development of the vaccine-induced Th1 response. The results suggest that B cells are required for the development of optimal protective anti-TB immunity upon BCG vaccination by regulating the IL-17/neutrophilic response. Administration of sera derived from M. tuberculosis-infected C57BL/6 wild-type mice reverses the lung neutrophilia phenotype in tuberculous μMT mice. Together, these observations provide insight into the mechanisms by which B cells and humoral immunity modulate vaccine-induced Th1 response and regulate neutrophila during M. tuberculosis infection and BCG immunization. © 2013 Kozakiewicz et al

pi+ + d --> p + p reaction between 18 and 44 MeV

A study of the reaction pi+ + d --> p + p has been performed in the energy range of 18 - 44 MeV. Total cross sections and differential cross sections at six angles have been measured at 15 energies with an energy increment of 1 - 2 MeV. This is the most systematic data set in this energy range. No structure in the energy dependence of the cross section has been observed within the accuracy of this experiment.Comment: 20 pages, 7 Postscript figure

Mesonic cloud contribution to the nucleon and delta masses

Pion-nucleon elastic scattering in the dominant $P_{33}$ channel is examined in the model in which the interaction is of the form $\pi + N\leftrightarrow N, \Delta(1232)$. New expressions are found for the elastic pion-nucleon scattering amplitude which differ from existing formula both in the kinematics and in the treatment of the renormalization of the nucleon mass and coupling constant. Fitting the model to the phase shifts in the $P_{33}$ channel does not uniquely fix the parameters of the model. The cutoff for the pion-nucleon form factor is found to lie in the range $\beta = 750\pm350$ MeV/c. The masses of the nucleon and the $\Delta$ which would arise if there were no coupling to mesons are found to be $m_{_N}^{(0)}= 1200\pm 200$ MeV and $m_\Delta^{(0)} = 1500\pm 200$ MeV. The difference in these bare masses, a quantity which would be accounted for by a residual gluon interaction, is found to be $\delta m^{(0)}=350\pm 100$ MeV.Comment: 26 pages, 9 figures, significant rewrit

Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System

Francisella tularensisis a facultative intracellular pathogen, and is the causative agent of a fatal human disease known as tularemia. F. tularensis is classified as a Category A Biothreat agent by the CDC based on its use in bioweapon programs by several countries in the past and its potential to be used as an agent of bioterrorism. No licensed vaccine is currently available for prevention of tularemia. In this study, we used a novel approach for development of a multivalent subunit vaccine against tularemia by using an efficient tobacco mosaic virus (TMV) based delivery platform. The multivalent subunit vaccine was formulated to contain a combination of F. tularensis protective antigens: OmpA-like protein (OmpA), chaperone protein DnaK and lipoprotein Tul4 from the highly virulent F. tularensisSchuS4 strain. Two different vaccine formulations and immunization schedules were used. The immunized mice were challenged with lethal (10xLD100) doses of F. tularensisLVS on day 28 of the primary immunization and observed daily for morbidity and mortality. Results from this study demonstrate that TMV can be used as a carrier for effective delivery of multiple F. tularensisantigens. TMV-conjugate vaccine formulations are safe and multiple doses can be administered without causing any adverse reactions in immunized mice. Immunization with TMV-conjugated F. tularensisproteins induced a strong humoral immune response and protected mice against respiratory challenges with very high doses of F. tularensis LVS. This study provides a proof-of-concept that TMV can serve as a suitable platform for simultaneous delivery of multiple protective antigens of F. tularensis. Refinement of vaccine formulations coupled with TMV-targeting strategies developed in this study will provide a platform for development of an effective tularemia subunit vaccine as well as a vaccination approach that may broadly be applicable to many other bacterial pathogens

Development of Functional and Molecular Correlates of Vaccine-Induced Protection for a Model Intracellular Pathogen, F. tularensis LVS

In contrast with common human infections for which vaccine efficacy can be evaluated directly in field studies, alternative strategies are needed to evaluate efficacy for slowly developing or sporadic diseases like tularemia. For diseases such as these caused by intracellular bacteria, serological measures of antibodies are generally not predictive. Here, we used vaccines varying in efficacy to explore development of clinically useful correlates of protection for intracellular bacteria, using Francisella tularensis as an experimental model. F. tularensis is an intracellular bacterium classified as Category A bioterrorism agent which causes tularemia. The primary vaccine candidate in the U.S., called Live Vaccine Strain (LVS), has been the subject of ongoing clinical studies; however, safety and efficacy are not well established, and LVS is not licensed by the U.S. FDA. Using a mouse model, we compared the in vivo efficacy of a panel of qualitatively different Francisella vaccine candidates, the in vitro functional activity of immune lymphocytes derived from vaccinated mice, and relative gene expression in immune lymphocytes. Integrated analyses showed that the hierarchy of protection in vivo engendered by qualitatively different vaccines was reflected by the degree of lymphocytes' in vitro activity in controlling the intramacrophage growth of Francisella. Thus, this assay may be a functional correlate. Further, the strength of protection was significantly related to the degree of up-regulation of expression of a panel of genes in cells recovered from the assay. These included IFN-γ, IL-6, IL-12Rβ2, T-bet, SOCS-1, and IL-18bp. Taken together, the results indicate that an in vitro assay that detects control of bacterial growth, and/or a selected panel of mediators, may ultimately be developed to predict the outcome of vaccine efficacy and to complement clinical trials. The overall approach may be applicable to intracellular pathogens in general

Analytical Method for the Simultaneous Estimation of Hydrochlorothiazide and Metoprolol Tartrate using RP HPLC

The present study deals with the estimation by RP-HPLC of two different drug components hydrochlorothiazide and metoprolol tartrate present in a tablet formulation. It is a simple, fast, precise and accurate high performance liquid chromatographic method. It is performed using phosphate buffer along with methanol as mobile phase, in the proportion of 60:40. The separation is done on a C18 column and it is estimated at a λmax of 226 nm with a flow of 1 ml/min. The detection limits range from a 0.013 to 0.075 mg/ml for hydrochlorothiazide and 0.10 to 0.60 mg/ml for metoprolol tartrate, respectively. The specificity for interference of any peak with main peak of interest is checked. A scan of the individual drug was taken for assuring the λmax. The system suitability by precision is also checked to ensure the analytical method. The method was found to be accurate and precise for estimation of the two drugs simultaneously

Estimation of obliquely scattered gamma-ray response functions in the gross-count tomographic gamma scanner (GC-TGS) Method

The gross-count tomographic gamma scanner (GC-TGS) method for assaying transuranic waste in 208-1 drums is being developed to allow NaI and other low-resolution gamma-ray detectors to be used in place of high-purity germanium (HPGe) detectors in TGS systems. It was recently shown that a logarithmic response-function technique based on the material basis set (MBS) formalism used in the TGS method allows gross spectra from NaI detectors to be used in both measuring MBS transmission corrections using external transmission sources and in applying the corrections to emission spectra to arrive at radionuclide mass estimates. In this work the authors have attempted to show that addition of the oblique scatter component can increase the accuracy of the GC-TGS measurements with both NaI and high-purity germanium detectors. This paper describes the formalism behind the GC-TGS method and the improvement achieved in the analysis by including the scatter component